New vaccine technology could protect from future viruses and variants
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants
Source: cam.ac.uk
Stay updated with breaking news from Uture Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants